Dixon Technologies Q2 FY27 Results Analysis: Revenue Jumps 47%, Margin Compresses 76 bps
Dixon Technologies (India) Ltd's Q2 FY27 numbers came in mixed, with revenue of Rs. 21,793.64 Cr (+46.71% YoY) and PAT growth of -44.90% YoY. Here's a quick read of what worked, what to watch, and what management said.
| Results date | October 30, 2026 |
|---|---|
| Revenue (Q2) | Rs. 21,793.64 Cr (+46.71% YoY) |
| PAT (Q2) | Rs. 410.87 Cr (-44.90% YoY) |
| EBITDA margin | 2.11% (-76 bps YoY) |
| EPS (Q2) | Rs. 67.44 (-45.44% YoY) |
Quarter Snapshot
Revenue grew 46.71% YoY to Rs.21,793.64 crore with normalized PAT up 18.16% YoY once prior-year one-off gains are stripped, but the clean operating margin of 2.11% is down 76 bps YoY. H1 operating cash flow was negative Rs.280.02 crore and the Rs.1,110.06 crore PLI receivable remains unresolved with auditor emphasis of matter. No quantified management guidance exists in the filing, so no guidance beat or miss can be established.
Q2 FY27 Expectations vs Results
| Driver | Expected before results | What happened | Verdict |
|---|---|---|---|
| Revenue | "revenue looks ahead YoY if the guided volume ramp held" — share gains against a −26% handset market | Rs.21,793.64 crore, +46.71% YoY, +40.17% QoQ | Played out |
| Margins | "margins likely flat to compressing… thin conversion margin, PLI/other-income dependence persisting" | Ex-OI margin 2.11% vs 2.14% Q1, 2.87% prior-year Q2 | Played out |
| PLI receivable | "Rs.1,110.06 Cr outstanding pending formal determination — the key cash-conversion overhang" | Note 6 confirms receivable still outstanding; amount booked in the quarter not disclosed; H1 CFO −Rs.280.02 crore | Played out |
| Mobile volumes vs 9–9.2m guided | Volume test of share gains | Not disclosed in the filing — open for the call | Not observable |
| Memory-cost pass-through | "how much of the chip-price spike flowed into customer-specified BOM pricing" | Materials ratio improved to 94.89% from 96.89% QoQ but no BOM-mix disclosure | Partially observable |
| Vivo JV / display ramp from Q3 | "Q2 remains a pre-JV quarter" | New 51% subsidiary incorporated; no JV revenue detail — consistent | Not observable |
| US tariff overhang | "the tariff overhang has so far not dented the export lane" | Not addressed in the filing — remains open for the call | Not observable |
Read our full results preview.
Management Guidance vs Delivery
| What management said | Where | What happened | Verdict |
|---|---|---|---|
| ~32m phones FY27 | Q1 FY27 earnings call (per pre-call note) | Not disclosed | Too Early |
| Margin pressure to continue through FY27 | Q1 FY27 management commentary (per pre-call note) | Operating EBITDA margin ex-other income 2.11% vs 2.87% prior-year Q2, 2.14% Q1 | Confirmed as a directional claim |
Key Investment Insights
Key Positives
- Consolidated revenue grew 46.71% YoY and 40.17% QoQ to Rs.21,793.64 crore; H1 revenue of Rs.37,341.30 crore is up 34.85% YoY
- Normalized PAT grew 18.16% YoY to Rs.410.87 crore after stripping Rs.492.92 crore of prior-year investment/slump-sale gains
- Operating EBITDA ex-other income grew 38.78% QoQ and 7.99% YoY to Rs.460.81 crore
- Materials ratio improved to 94.89% of revenue from 96.89% in Q1 FY27
- Employee costs grew only 9.55% YoY and other expenses declined 1.10% YoY against 46.71% revenue growth
- Finance costs fell 32.33% YoY to Rs.25.95 crore; net debt of Rs.167.52 crore is modest against Rs.6,728.43 crore of equity
- Inventory days of 29.2 are essentially unchanged from FY26's 28.7, indicating the inventory build tracks the revenue run-rate
Risk Factors
- H1 operating cash flow was negative Rs.280.02 crore (vs +Rs.880.84 crore in H1 FY26) with FCF of −Rs.986.94 crore
- Rs.1,110.06 crore PLI receivable remains outstanding pending formal determination, flagged in the auditors' emphasis-of-matter paragraph
- Operating EBITDA margin ex-other income compressed 76 bps YoY to 2.11% from 2.87%
- Effective tax rate rose to 22.82% from 17.39% in Q1 and 19.26% in the prior-year quarter
- Reported consolidated PAT fell 44.90% YoY and standalone PAT fell 74.20% YoY
- NCI share of Q2 PAT rose to 16.36% from 10.15% a year ago, reducing profit accrual to owners
Ask about this
Ask Cofacto a question about this result. Answers cite filings and company data.
Related
Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.